Pulse Biosciences (PLSE) Share-based Compensation Growth (1y) (2016 - 2026)
Pulse Biosciences (PLSE) Share-based Compensation Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 314.20% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 14.58% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 10.53% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 10.94% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 93.33% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 47.30% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 11.76% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -5.71% |
| 10 | Pulse Biosciences | 3.50 Bn | 3.50 Bn | 161,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,323.70% |
| Dec 31, 2025 | -342.71% |
| Sep 30, 2025 | 88.36% |
| Jun 30, 2025 | 152.88% |
| Mar 31, 2025 | 222.97% |
| Dec 31, 2024 | 110.41% |
| Sep 30, 2024 | 65.85% |
| Jun 30, 2024 | 79.53% |
| Mar 31, 2024 | 96.32% |
| Sep 30, 2023 | 148.69% |
| Jun 30, 2023 | -33.27% |
| Mar 31, 2023 | -55.36% |
| Sep 30, 2022 | -54.15% |
| Jun 30, 2022 | -30.02% |
| Mar 31, 2022 | -52.21% |
| Dec 31, 2021 | 94.83% |
| Sep 30, 2021 | -40.47% |
| Jun 30, 2021 | 1.49% |
| Mar 31, 2021 | 59.94% |
| Sep 30, 2020 | -1.12% |